Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Pain Headache Rep ; 23(7): 48, 2019 May 30.
Article in English | MEDLINE | ID: mdl-31147838

ABSTRACT

PURPOSE OF REVIEW: Total patient care is of extreme importance during the administration of anesthesia. Proper care of the eye is necessary during all anesthetic administrations, especially during the administration of general anesthesia or monitored anesthesia care. By paying attention to details, the likelihood of an occurrence of eye injuries is reduced. RECENT FINDINGS: Though perioperative eye injuries are rare during general anesthesia, they do account for 2-3% of claims against anesthesiologists. Ocular injuries may occur during general anesthesia even when tape has been utilized for eye closure. Corneal abrasions are the most common injuries that have been attributed to direct trauma to the eye, exposure keratopathy, or chemical injury. Using a hydrogel patch during general anesthesia is also associated with more frequent corneal injury than previously thought. Prevention of anesthesia-related eye injuries assumes a high priority since the eye is one of the major sense organs of the body. The eye can be damaged during anesthesia for both non-ophthalmic and ophthalmic surgeries.


Subject(s)
Anesthesia, General , Corneal Injuries/diagnosis , Corneal Injuries/therapy , Ophthalmologic Surgical Procedures , Postoperative Complications/surgery , Anesthesia, General/adverse effects , Anesthesiology/methods , Humans , Postoperative Period
2.
Curr Pain Headache Rep ; 22(5): 32, 2018 Apr 04.
Article in English | MEDLINE | ID: mdl-29619569

ABSTRACT

PURPOSE OF REVIEW: In the USA, there has been a sharp increase in heroin, prescription opiate, and illicitly manufactured fentanyl abuse with overdoses tripling since the 1990s. Several states have been deemed as "high-burden" abuse states where there is a greater proportion of synthetic opiate use. During the same period that prescription limitations were initially implemented throughout the country, the fentanyl epidemic started nationwide. RECENT FINDINGS: In the setting of data demonstrating an almost fourfold increase in overdose deaths from 1999 to 2008, states began restricting access to Food and Drug Agency (FDA) approved opioid medications. Another factor further exacerbating the opioid crises is that the cost of all formulations of naloxone has increased significantly over the past several years. In order to combat the opioid epidemic, stricter prescribing practices and prescription-monitoring programs have been instituted. Also, improvements in abuse-deterrent strategies for all opioid preparations can play an important role by increasing the safety of these medications and is a major focus of the FDA.


Subject(s)
Epidemics , Opioid-Related Disorders/epidemiology , Humans , United States/epidemiology
3.
Curr Opin Support Palliat Care ; 12(2): 124-130, 2018 06.
Article in English | MEDLINE | ID: mdl-29465470

ABSTRACT

PURPOSE OF REVIEW: The primary cause of overdose death in the United States is related to pharmaceutical opioids. A few particular populations that struggle with adverse outcomes related to opioid abuse are those in palliative care, those with chronic pain, and those receiving pain treatments secondary to cancer or chemotherapy. RECENT FINDINGS: There have been massive efforts to decrease the use of opioid abuse in patient care in a gestalt manner, but palliative care provides unique challenges in applying these reduction tactics used by other specialties. SUMMARY: We explore behavioral interventions, provider education, alternative pain management techniques, postmarketing surveillance, and abuse-deterrent formulas as emerging methods to counteract opioid abuse in these populations.


Subject(s)
Analgesics, Opioid/therapeutic use , Cancer Pain/drug therapy , Chronic Pain/drug therapy , Opioid-Related Disorders/epidemiology , Prescription Drug Diversion/statistics & numerical data , Abuse-Deterrent Formulations/methods , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Delayed-Action Preparations , Humans , Opioid-Related Disorders/mortality , Pain Management/methods , Palliative Care , Practice Guidelines as Topic , Practice Patterns, Physicians' , Prescription Drug Diversion/prevention & control , Product Surveillance, Postmarketing/methods , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...